a50895103.htm
0UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 11-K
FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS
AND SIMILAR PLANS PURSUANT TO SECTION 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
|
(Mark One)
|
|
|
X
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31, 2013
| Or |
| |
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the transition period from
to
Commission File Number: 1-3619
|
A.
|
Full title of the Plan and the address of the plan, if different from that of the issuer named
below:
|
WYETH UNION SAVINGS PLAN
|
B.
|
Name of issuer of the securities held pursuant to the plan and the address of its principal
executive office:
|
PFIZER INC.
235 EAST 42ND STREET
NEW YORK, NEW YORK 10017
WYETH UNION SAVINGS PLAN
DECEMBER 31, 2013 AND 2012
INDEX
| *Note: |
Other schedules required by 29 CFR 2520.103-10 of the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974, as amended, have been omitted because they are not applicable. |
|
To the Savings Plan Committee
Wyeth Union Savings Plan:
We have audited the accompanying statements of net assets available for plan benefits of the Wyeth Union Savings Plan (the Plan) as of December 31, 2013 and 2012 and the related statements of changes in net assets available for plan benefits for each of the years then ended. These financial statements are the responsibility of the Plan's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for plan benefits of the Plan as of December 31, 2013 and 2012, and the changes in net assets available for plan benefits for the years then ended, in conformity with accounting principles generally accepted in the United States of America.
Our audits were conducted for the purpose of forming an opinion on the basic financial statements taken as a whole. The supplemental Schedule H, Line 4i - Schedule of Assets (Held at End of Year) as of December 31, 2013 and Schedule H, Line 4j - Schedule of Reportable Transactions for the Year Ended December 31, 2013 are presented for the purpose of additional analysis and are not a required part of the basic financial statements but are supplementary information required by the Department of Labor's Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. These supplemental schedules are the responsibility of the Plan's management. The supplemental schedules have been subjected to the auditing procedures applied in the audit of the basic financial statements and, in our opinion, are fairly stated in all material respects in relation to the basic financial statements taken as a whole.
Memphis, Tennessee
June 26, 2014
STATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS
As of December 31, 2013 and 2012
| |
|
December 31,
|
|
| |
|
2013
|
|
|
2012
|
|
|
Assets:
|
|
|
|
|
|
|
|
Investments, at fair value:
|
|
|
|
|
|
|
|
Pfizer Inc. common stock
|
|
$ |
2,868,714 |
|
|
$ |
2,154,372 |
|
|
Zoetis Inc. common stock
|
|
|
21,837 |
|
|
|
- |
|
|
Common/collective trust funds
|
|
|
60,772,540 |
|
|
|
58,364,840 |
|
|
Mutual funds
|
|
|
4,823,900 |
|
|
|
3,731,401 |
|
|
Total investments, at fair value
|
|
|
68,486,991 |
|
|
|
64,250,613 |
|
| |
|
|
|
|
|
|
|
|
|
Receivables:
|
|
|
|
|
|
|
|
|
|
Notes receivable from participants
|
|
|
1,226,593 |
|
|
|
1,336,458 |
|
|
Pending trade sales
|
|
|
- |
|
|
|
21,534 |
|
|
Total receivables
|
|
|
1,226,593 |
|
|
|
1,357,992 |
|
|
Total assets
|
|
|
69,713,584 |
|
|
|
65,608,605 |
|
| |
|
|
|
|
|
|
|
|
|
Liabilities:
Investment management fees payable
|
|
|
2,490 |
|
|
|
6,200 |
|
| |
|
|
|
|
|
|
|
|
|
Net assets available for plan benefits before adjustment
|
|
|
69,711,094 |
|
|
|
65,602,405 |
|
| |
|
|
|
|
|
|
|
|
|
Adjustment from fair value to contract value for fully
|
|
|
|
|
|
|
|
|
|
benefit-responsive investment contracts
|
|
|
(343,419 |
) |
|
|
(1,091,783 |
) |
| |
|
|
|
|
|
|
|
|
|
Net assets available for plan benefits
|
|
$ |
69,367,675 |
|
|
$ |
64,510,622 |
|
See accompanying Notes to Financial Statements.
STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS
For the Years Ended December 31, 2013 and 2012
| |
|
|
|
| |
|
Year Ended December 31,
|
|
| |
|
2013 |
|
|
2012 |
|
| |
|
|
|
|
|
|
|
Additions/(reductions):
|
|
|
|
|
|
|
|
Additions/(reductions) to net assets attributed to:
|
|
|
|
|
|
|
|
Investment income:
|
|
|
|
|
|
|
|
Net appreciation in investments
|
|
$ |
8,962,286 |
|
|
$ |
5,145,697 |
|
|
Pfizer Inc. common stock dividends
|
|
|
87,627 |
|
|
|
74,150 |
|
|
Other dividends
|
|
|
422,171 |
|
|
|
822,344 |
|
|
Total investment income
|
|
|
9,472,084 |
|
|
|
6,042,191 |
|
|
Interest income from notes receivable from participants
|
|
|
56,945 |
|
|
|
84,088 |
|
|
Less: Investment management, redemption and loan fees
|
|
|
(7,929 |
) |
|
|
(7,917 |
) |
|
Net investment and interest income
|
|
|
9,521,100 |
|
|
|
6,118,362 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contributions:
|
|
|
|
|
|
|
|
|
|
Participant
|
|
|
3,164,116 |
|
|
|
3,714,595 |
|
|
Company
|
|
|
864,547 |
|
|
|
1,076,445 |
|
|
Rollovers into Plan
|
|
|
109,067 |
|
|
|
574,556 |
|
|
Total contributions
|
|
|
4,137,730 |
|
|
|
5,365,596 |
|
|
Total additions, net
|
|
|
13,658,830 |
|
|
|
11,483,958 |
|
|
|
|
|
|
|
|
|
|
|
|
Deductions:
|
|
|
|
|
|
|
|
|
|
Deductions from net assets attributed to:
|
|
|
|
|
|
|
|
|
|
Benefits paid to participants
|
|
|
8,801,777 |
|
|
|
11,621,188 |
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease)
|
|
|
4,857,053 |
|
|
|
(137,230 |
) |
| |
|
|
|
|
|
|
|
|
|
Net assets available for plan benefits:
|
|
|
|
|
|
|
|
|
|
Beginning of year
|
|
|
64,510,622 |
|
|
|
64,647,852 |
|
|
End of year
|
|
$ |
69,367,675 |
|
|
$ |
64,510,622 |
|
See accompanying Notes to Financial Statements.
Notes to Financial Statements
December 31, 2013 and 2012
| 1. |
Description of the Plan |
General
On October 15, 2009, Pfizer Inc. (the Company or the Plan Sponsor) acquired all of the outstanding equity of Wyeth. In connection with the acquisition, the Company adopted and assumed sponsorship of the Wyeth Union Savings Plan (the Plan) effective October 15, 2009. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA) and the Internal Revenue Code of 1986 as amended (the Code).
The Plan, a defined contribution plan of legacy Wyeth, is a voluntary savings plan available to all eligible employees, as defined in the Plan. Employees become eligible to participate after they have completed 30 days of regular employment, as defined by the Plan, and whose employment is covered by a collective bargaining agreement that provides for their participation.
On June 24, 2013, the Plan sponsor completed the full disposition of its Animal Health business. The full disposition was completed through a series of steps, including, in the first quarter of 2013, the formation of Zoetis Inc. (Zoetis) and an initial public offering of an approximate 19.8% interest in Zoetis and, in the second quarter of 2013, an exchange offer for the remaining 80.2% interest. In connection with the exchange offer, Plan participants holding Pfizer common stock units within the Plan were offered the opportunity to exchange all or a portion of their Pfizer common stock units held in the Plan for units of Zoetis common stock under a new Zoetis Stock Fund within the Plan. In June 2014, actions were taken to eliminate the Zoetis Stock Fund. See Note 11, Subsequent Events, for additional information.
The following is a general description of certain provisions of the Plan. Participants should refer to the Plan document for more complete information.
Plan Administration
The Savings Plan Committee of the Plan Sponsor monitors and reports on the selection and termination of the trustee, custodian, and investment managers, and on the investment activity and performance of the Plan.
Administrative Costs
In general, except for investment management fees associated with certain investment fund options, costs and expenses of administering the Plan are paid and absorbed by the Plan or the Plan Sponsor. The Plan’s administrative expenses may be paid for through offsets and/or payments associated with one or more of the Plan’s investment options.
Contributions
Participants may elect to make contributions to the Plan in whole percentages up to a maximum of 16% of eligible compensation, as defined in the Plan. Contributions can be made on a before-tax basis (“salary deferral contributions”), an after-tax basis (“after-tax contributions”), or a combination of both. Participants direct the investment of their contributions into various investment options offered by the Plan. Any contributions, for which the participant does not provide investment direction, are invested in the Plan’s Qualified Default Investment Alternative (QDIA) fund, which is generally the Vanguard Target Retirement Trust Plus Fund based on the participant’s year of birth. Under the Code, salary deferral contributions, total annual contributions, and the amount of compensation that can be included for Plan purposes are subject to annual limitations; any excess contributions are refunded to participants in the following year, if applicable.
The Company makes a matching contribution equal to 50% of the first 6% of the participant’s eligible compensation. The Company contributions are invested based on the participant elected allocation. If an allocation is not selected, then the Company contributions are invested in accordance with the participant’s allocation for their employee contributions.
Rollovers into Plan
Participants may elect to rollover one or more account balances from qualified plans, as well as from the Wyeth Coordinated Bargaining Retirement Plan – U.S., into the Plan.
Investment Options
Participants can elect to invest amounts credited to their account in any of the investment funds offered by the Plan and transfer amounts between these funds at any time during the year. Investment elections must be made in multiples of 1%. Transfers between funds must be made in whole percentages and/or in an amount of at least $250 and may be made on a daily basis. Based on the investment option, certain short-term redemption fees may apply.
Each participant in the Plan elects to have his or her contributions and employer matching contributions invested in any one or combination of investment funds in the Plan.
Vesting and Separation from Service
Participants are fully vested at all times in their salary deferral contributions, after-tax contributions, and rollover contributions and all earnings (losses) thereon. A participant is also fully vested in Company matching contributions if the participant has at least five years of vesting service, as defined in the Plan. If a participant has less than five years of continuous service, such participant becomes vested in the Company matching contributions and all earnings (losses) thereon according to the following schedule:
|
Years of Vesting Service
|
|
Vesting Percentage
|
|
1 year completed
|
|
0%
|
|
2 years completed
|
|
25%
|
|
3 years completed
|
|
50%
|
|
4 years completed
|
|
75%
|
|
5 years completed
|
|
100%
|
Regardless of the number of years of vesting service, participants are fully vested in their Company matching contributions account upon reaching age 65 or upon death, if earlier. If a participant’s employment is terminated prior to full vesting, the non-vested portion of the Company matching contributions and all earnings thereon are forfeited and become available to satisfy future Company matching contributions.
Forfeited Amounts
Forfeited balances of terminated participants’ nonvested accounts are used to reduce future Company contributions. At December 31, 2013 and 2012, forfeited nonvested accounts available to reduce future Company matching contributions totaled $15,569 and $45,388, respectively.
Distributions
Participants may withdraw all or any portion of their after-tax contributions. Participants may make full or partial withdrawals of funds in any of their accounts upon attaining age 59½ or for financial hardship, as defined in the Plan, before that age. Participants may qualify for financial hardship withdrawals if they have an immediate and heavy financial need, as determined by the plan administrator. The minimum withdrawal for an after-tax or hardship withdrawal is $500; there is no minimum if the participant is over age 59½. Participants are limited to one withdrawal per calendar quarter. Participants cannot make contributions for six months after taking a hardship withdrawal.
Upon termination of employment, participants are entitled to a distribution of their vested account balance in one of two ways: lump-sum or monthly payments of 60, 120, 180, 240, 300, or 360 months. If a participant was in the Plan on or prior to January 1, 1996, he/she may elect a joint and 50% survivor annuity.
Payments commence as soon as practicable following a request, but in no event later than the date of termination or April 1 in the year following the year in which the participant turns 70½ years of age. Participants can elect to defer the distribution of their accounts if the participant’s account balance is greater than $1,000.
Notes Receivable from Participants
Plan participants who have a vested account balance of at least $2,000 may borrow from the vested portion of their account. The minimum amount a participant may borrow is $1,000 and the maximum amount is the lesser of 50% of the account balance reduced by any current outstanding loan balance, or $50,000, reduced by the highest outstanding loan balance in the preceding 12 months.
Under the terms of the Plan, loans must be repaid within five years, unless the funds are used to purchase a primary residence. Primary residence loans must be repaid within 15 years. The interest rate on all loans is based on the prime rate and is set by the plan administrator. Interest rates on outstanding loans ranged from 4.25% to 9.50% at December 31, 2013 and 2012.
Interest paid by the participant is credited to the participant's account. Interest income from notes receivable from participants is recorded by the trustee as earned in the investment funds in the same proportion as the original loan issuance. Repayments may not necessarily be made to the same fund from which the amounts were borrowed. Repayments are credited to the applicable funds based on the participant’s investment elections at the time of repayment.
For terminating participants who defer distribution of their account balance, repayment of the loan must be made in full. For terminating participants who receive an immediate distribution of their account balance, the distribution will be made net of the outstanding loan balance.
Defaults on participant loans during the year are treated as distributions and are fully taxable to the participants.
Benefit Payments
Benefits are recorded when paid.
Plan Termination
The Plan Sponsor expects to continue the Plan indefinitely, but reserves the right to amend, suspend, or discontinue it in whole or in part at any time by action of the Plan Sponsor's Board of Directors or its authorized designee. In the event of termination of the Plan, each participant shall be entitled to the full value of his or her account balance as though he or she had retired as of the date of such termination. No part of the invested assets established pursuant to the Plan will at any time revert to the Company, except as otherwise permitted under ERISA.
| 2. |
Summary of Significant Accounting Policies |
Basis of Accounting
The financial statements of the Plan are prepared on the accrual basis of accounting. Benefit payments are recorded when paid.
Investment contracts held by a defined contribution plan are required to be reported at fair value. However, contract value is the relevant measurement attribute for that portion of the net assets available for benefits of a defined contribution plan attributable to fully benefit-responsive investment contracts because contract value is the amount participants would receive if they were to initiate permitted transactions under the terms of the plan. As required, the accompanying statements of net assets available for plan benefits present the fair value of the investment contracts, as well as the adjustment of the fully benefit-responsive investment contracts from fair value to contract value. The statements of changes in net assets available for plan benefits are prepared on a contract value basis.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires Plan management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, the reported amounts of increases and decreases to net assets during the reporting period, and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.
Contributions
Contributions from the employer are accrued based upon amounts required to be funded under the provisions of the Plan. Contributions from employees are accrued when deducted from payroll.
Participant Accounts
Each participant account is credited with the participant’s contribution, investment earnings (losses), and Company contributions, and such accounts may be charged with certain investment fees, depending on the investment options. Allocations are based on earnings (losses) or account balance, as defined in the Plan document.
Investment Valuation
Common stock is valued at the closing market price on the last business day of the year. Common/collective trust funds (CCTs), except for the investment in the T. Rowe Price Stable Value Common Trust Fund, are stated at redemption value as determined by the trustees of such funds based upon the underlying securities stated at fair value. The T. Rowe Price Stable Value Common Trust Fund represents a common/collective trust fund with an underlying investment in Guaranteed Investment Contracts (GICs), Bank Investment Contracts (BICs), Synthetic Investment Contracts (SICs), and Separate Account Contracts (SACs), collectively, investment contracts. The investment contracts within the T. Rowe Price Stable Value Common Trust Fund are reported at fair value by the issuer insurance companies and banks with an appropriate adjustment to report such contracts at contract value because these investments are fully benefit-responsive. Mutual funds are recorded at fair value based on the closing market prices obtained from national exchanges of the underlying investments of the respective fund as of the last business day of the year. See Note 5, Investment Contracts, for additional information.
See Note 6, Fair Value Measurements, for additional information regarding the fair value of the Plan’s investments.
Notes Receivable from Participants
Notes receivable from participants, which are subject to various interest rates, are recorded at amortized cost.
Risks and Uncertainties
Investment securities, including Pfizer Inc. common stock and Zoetis Inc. common stock, are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in their fair values could occur in the near term and that such changes could materially affect participants' account balances and the amounts reported in the statements of net assets available for plan benefits.
Investment Transactions
Purchases and sales of securities are reflected on a trade-date basis. Dividend income is recorded on the ex-dividend date. Interest income is recorded as earned.
Net Appreciation in Investments
The Plan presents, in the statements of changes in net assets available for plan benefits, the net appreciation in the value of its investments which consists of the realized gains and losses and the unrealized gains and losses on those investments and the change in contract value of the fund holding investments in GICs, BICs, SICs, and SACs. Realized gains and losses on sales of investments represent the difference between the net proceeds and the cost of the investments (average cost if less than the entire investment is sold). Unrealized gains and losses on investments represent the difference between the cost of the investments and their fair value at the end of the year.
The Internal Revenue Service (IRS) has determined and informed the Plan Sponsor by letter dated February 20, 2008 that the Plan and related trust are designed in accordance with the applicable sections of the Code. The Plan has been amended since receiving the determination letter. However, the Company's counsel believes the Plan is currently designed and being operated in compliance with the applicable requirements of the Code. Accordingly, no provision has been made for U.S. federal income taxes in the accompanying financial statements.
U.S. GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability (or asset) if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the (IRS). The Company’s counsel has confirmed that there are no uncertain positions taken that would require recognition of a liability (or asset) or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress. The Plan administrator believes it is generally no longer subject to income tax examinations for years prior to 2010.
The fair value of individual investments that represented 5% or more of the Plan’s net assets available for plan benefits were as follows:
| |
|
|
|
| |
|
|
December 31,
|
| |
|
2013 |
|
2012 |
|
| |
|
|
|
|
|
|
|
|
|
T. Rowe Price Stable Value Common Trust Fund
|
|
$ |
24,573,928 |
|
|
$ |
26,487,992 |
|
|
NTGI S&P 500 Equity Index Fund – Lending
|
|
|
20,436,997 |
|
|
|
18,628,471 |
|
|
BlackRock U.S. Debt Index Fund K
|
|
|
2,459,478 |
|
|
|
3,396,594 |
|
The Plan's investments (including gains and losses on investments sold, as well as held during the year) appreciated in value as follows:
| |
|
|
|
| |
|
|
|
|
| |
|
2013 |
|
2012 |
|
| |
|
|
|
|
|
|
|
|
| Net appreciation in investments: |
|
|
|
|
|
|
|
|
|
Mutual Funds
|
|
$ |
986,588 |
|
|
$ |
590,515 |
|
|
Collective Trusts
|
|
|
7,471,544
|
|
|
|
4,266,392
|
|
| Common Stock |
|
|
504,154 |
|
|
|
288,790
|
|
| |
|
|
$8,962,286
|
|
|
|
$5,145,697
|
|
The T. Rowe Price Stable Value Fund consists primarily of GICs, BICs, SICs, and SACs within the T. Rowe Price Stable Value Common Trust Fund, which is a collective trust fund that invests primarily in fully benefit-responsive contracts. The contract value of the investment contracts represents contributions made under the contract and related earnings offset by participant withdrawals. There are no reserves against contract value for credit risk of the contract issuers or otherwise.
At December 31, 2013 and 2012, the contract value of the Plan’s investments in the T. Rowe Price Stable Value Common Trust Fund was approximately $24 million and $25 million, respectively. The average portfolio yields for the years ended December 31, 2013 and 2012 for the T. Rowe Price Stable Value Common Trust Fund were approximately 2.06% and 2.36%, respectively. The crediting interest rates for the years ended December 31, 2013 and 2012 were approximately 2.29% and 2.45%, respectively.
Traditional investment contracts, such as GICs or BICs, provide for a fixed return on principal invested for a specified period of time. The issuer of a traditional contract is a financially responsible counterparty, typically an insurance company, bank, or other financial services institution. The issuer accepts a deposit from a benefit plan or collective trust fund and purchases investments, which are held by the issuer. The issuer is contractually obligated to repay principal and interest at the stated coupon rate to the plan or collective trust fund and guarantees liquidity at contract value prior to maturity for routine permitted participant-initiated withdrawals from a stable value fund that holds these investment contracts. “Permitted participant-initiated withdrawals” refers to withdrawals from the stable value fund which directly result from participant transactions allowed by a benefit plan, such as participant withdrawals for benefits, loans, or transfers to other funds or trusts within the benefit plan.
In contrast to traditional investment contracts, the investments underlying a synthetic structure are owned by the Trust. SICs consist of a portfolio of underlying assets owned by a benefit plan and a wrap contract issued by a financially responsible third party, typically an insurance company, bank, or other financial services institution. The issuer of the wrap contract provides for unscheduled withdrawals from the contract at contract value, regardless of the value of the underlying assets, in order to fund routine permitted participant-initiated withdrawals from a stable value fund. SICs provide for a variable crediting rate, which typically resets at least quarterly, and the issuer of the wrap contract provides assurance that future adjustments to the crediting rate cannot result in a crediting rate less than zero.
SACs share certain attributes of both traditional and synthetic investment contracts. A SAC is a contract with a financially responsible counterparty, typically an insurance company. The issuer guarantees liquidity at contract value for permitted participant-initiated withdrawals from the collective trust fund and provides for a variable crediting rate, not less than zero, based on performance of an underlying portfolio of investments. The issuer accepts a deposit of cash and/or securities from the collective trust fund to create the underlying fixed income portfolio. The underlying portfolio holdings are owned by the issuer but are required to be segregated in a separate account and are designed to be protected from the claims of the issuer’s general creditors in the event of issuer insolvency. As with a SIC, to the extent the portfolio underlying a SAC is insufficient to cover payment obligations under the contract, the issuer is contractually obligated to make such payments in full. The SAC provides that gains and losses on the underlying portfolio accrue to the benefit of the trust. SACs have no stated maturity but may be discontinued by either party subject to any notice period under the terms of the SAC.
The crediting rate is based, in part, on the relationship between the contract value and the market value of the underlying assets, as well as previously realized gains and losses on underlying assets. The crediting rate will generally reflect, over time, movements in prevailing interest rates. However, at times the crediting rate may be more or less than prevailing rates or the actual income earned on the underlying assets. In most cases, realized and unrealized gains and losses on the underlying investments are not reflected immediately in the net assets of a stable value fund, but rather are amortized either over the time to maturity or the duration of the underlying investments, through adjustments to the future interest crediting rate.
The existence of certain conditions can limit a benefit plan’s or collective trust fund’s ability to transact at contract value with the issuers of its investment contracts. Specifically, any event outside the normal operation of a benefit plan or collective trust which causes a withdrawal from an investment contract may result in a contract value adjustment with respect to such withdrawal. Examples of such events include, but are not limited to, partial or complete legal termination of the plan or collective trust fund, tax disqualification, certain plan or trust amendments if issuers' consent is not obtained, improper communications to participants, group terminations, group layoffs, early retirement programs, mergers, sales, spin-offs, and bankruptcy.
In addition to the limitations noted above, issuers of investment contracts have certain rights to terminate a contract and settle at an amount which differs from contract value. For example, certain breaches by a benefit plan or the investment manager of their obligations, representations, or warranties under the terms of an investment contract can result in its termination at market value, which may differ from contract value. Investment contracts may also provide for termination with no payment obligation from the issuer if the performance of the contract constitutes a prohibited transaction under ERISA or other applicable law. SICs and SACs may also provide issuers with the right to reduce contract value in the event an underlying security suffers a credit event or terminate the contract in the event certain investment guidelines are materially breached and not cured.
| 6. |
Fair Value Measurements |
The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs to fair value measurements - Level 1 meaning the use of quoted prices for identical instruments in active markets; Level 2 meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; and Level 3 meaning the use of unobservable inputs.
See Note 2, Summary of Significant Accounting Policies: Investment Valuation, for information regarding the methods used to determine the fair value of the Plan’s investments. These methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
The following tables set forth by level, within the fair value hierarchy, the Plan’s investments at fair value as of December 31, 2013 and 2012:
|
Investments at Fair Value as of December 31, 2013
|
|
| |
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Common/Collective Trusts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US Large Cap Equity
|
|
$ |
- |
|
|
$ |
20,554,266 |
|
|
$ |
- |
|
|
$ |
20,554,266 |
|
|
US Small/Mid Cap Equity
|
|
|
- |
|
|
|
2,664,430 |
|
|
|
- |
|
|
|
2,664,430 |
|
|
Fixed Income
|
|
|
- |
|
|
|
27,129,388 |
|
|
|
- |
|
|
|
27,129,388 |
|
|
Retirement Target Date
|
|
|
- |
|
|
|
10,424,456 |
|
|
|
- |
|
|
|
10,424,456 |
|
| |
|
|
- |
|
|
|
60,772,540 |
|
|
|
- |
|
|
|
60,772,540 |
|
|
Mutual Funds:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US Large Cap Equity
|
|
|
851,697 |
|
|
|
- |
|
|
|
- |
|
|
|
851,697 |
|
|
US Small/Mid Cap Equity
|
|
|
1,291,336 |
|
|
|
- |
|
|
|
- |
|
|
|
1,291,336 |
|
|
Non-US Equity
|
|
|
2,603,597 |
|
|
|
- |
|
|
|
- |
|
|
|
2,603,597 |
|
|
Self-directed BrokerageLink
|
|
|
77,270 |
|
|
|
- |
|
|
|
- |
|
|
|
77,270 |
|
|
|
|
|
4,823,900 |
|
|
|
- |
|
|
|
- |
|
|
|
4,823,900 |
|
|
Common Stocks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer Inc. Common Stock
|
|
|
2,868,714 |
|
|
|
- |
|
|
|
- |
|
|
$ |
2,868,714 |
|
|
Zoetis Inc. Common Stock
|
|
|
21,837 |
|
|
|
- |
|
|
|
- |
|
|
|
21,837 |
|
|
|
|
|
2,890,551 |
|
|
|
- |
|
|
|
- |
|
|
|
2,890,551 |
|
|
Total Investments at Fair Value
|
|
$ |
7,714,451
|
|
|
$ |
60,772,540 |
|
|
$ |
- |
|
|
$ |
68,486,991 |
|
| |
|
Investments at Fair Value as of December 31, 2012
|
|
| |
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Common/Collective Trusts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US Large Cap Equity
|
|
$ |
- |
|
|
$ |
18,628,471 |
|
|
$ |
- |
|
|
$ |
18,628,471 |
|
|
US Small/Mid Cap Equity
|
|
|
- |
|
|
|
2,011,431 |
|
|
|
- |
|
|
|
2,011,431 |
|
|
Fixed Income
|
|
|
- |
|
|
|
30,207,681 |
|
|
|
- |
|
|
|
30,207,681 |
|
|
Retirement Target Date
|
|
|
- |
|
|
|
7,517,257 |
|
|
|
- |
|
|
|
7,517,257 |
|
| |
|
|
- |
|
|
|
58,364,840 |
|
|
|
- |
|
|
|
58,364,840 |
|
|
Mutual Funds:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
US Large Cap Equity
|
|
|
780,532 |
|
|
|
- |
|
|
|
- |
|
|
|
780,532 |
|
|
US Small/Mid Cap Equity
|
|
|
719,425 |
|
|
|
- |
|
|
|
- |
|
|
|
719,425 |
|
|
Non-US Equity
|
|
|
2,179,966 |
|
|
|
- |
|
|
|
- |
|
|
|
2,179,966 |
|
|
Self-directed BrokerageLink
|
|
|
51,478 |
|
|
|
- |
|
|
|
- |
|
|
|
51,478 |
|
|
|
|
|
3,731,401 |
|
|
|
- |
|
|
|
- |
|
|
|
3,731,401 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pfizer Inc. Common Stock
|
|
|
2,154,372 |
|
|
|
- |
|
|
|
- |
|
|
|
2,154,372 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments at Fair Value
|
|
$ |
5,885,773
|
|
|
$ |
58,364,840 |
|
|
$ |
- |
|
|
$ |
64,250,613 |
|
| 7. |
Related-Party Transactions |
The trustee of the Plan, Northern Trust Company, manages investments in its sponsored funds and, therefore, is deemed a party-in-interest and a related party. The record keeper of the Plan, Fidelity Management Trust Company, manages investments in its sponsored funds and, therefore, is deemed a party-in-interest and a related party. The Plan also invests in shares of the Plan sponsor; therefore, these transactions qualify as party-in-interest transactions.
| 8. |
Reconciliation of Financial Statements to Form 5500 |
Investments in the T. Rowe Price Stable Value Common Trust Fund are reported on Form 5500 at fair value, whereas the net assets available for plan benefits in the financial statements report such investments at contract value.
The following is a reconciliation of net assets available for plan benefits per the financial statements to the Plan's Form 5500 filed for 2012 and expected to be filed for 2013:
| |
|
December 31,
|
|
| |
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
Net assets available for plan benefits per the financial statements
|
|
$ |
69,367,675 |
|
|
$ |
64,510,622 |
|
|
Adjustment of T. Rowe Price Stable Value Common Trust Fund from contract value to fair value
|
|
|
343,419 |
|
|
|
1,091,783 |
|
|
Net assets available for plan benefits per the Form 5500
|
|
$ |
69,711,094 |
|
|
$ |
65,602,405 |
|
The following is a reconciliation of total investment income per the financial statements to the Form 5500 for the year ended December 31, 2013 and 2012:
| |
|
Year Ended December 31,
|
|
| |
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
Total investment income per the financial statements
|
|
$ |
9,472,084 |
|
|
$ |
6,042,191 |
|
|
Adjustment of T. Rowe Price Stable Value Common Trust Fund from contract value to fair value at end of year
|
|
|
343,419 |
|
|
|
1,091,783 |
|
|
Adjustment of T. Rowe Price Stable Value Common Trust Fund from contract value to fair value at beginning of year
|
|
|
(1,091,783 |
) |
|
|
(980,005 |
) |
|
Total investment income per the Form 5500
|
|
$ |
8,723,720 |
|
|
$ |
6,153,969 |
|
At the close of business on June 25, 2014, the fiduciary and investment manager of the Zoetis Stock Fund, Evercore Trust Company, N.A. (Evercore), directed the Northern Trust Company, the Plan’s trustee, to liquidate the shares of Zoetis stock in the Zoetis Stock Fund. Once the sale of the Zoetis stock is completed, Evercore has directed Fidelity Management Trust Company, the Plan’s record keeper, to transfer the remaining assets in the Zoetis Stock Fund to each participant’s QDIA fund. This transaction is expected to be complete by July 7, 2014
The Plan Sponsor has evaluated subsequent events from the statement of net assets available for plan benefits date through June 26, 2014, the date at which the financial statements were available to be issued, and determined there were no additional items to disclose.
|
|
|
|
SCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)
|
|
|
As of December 31, 2013
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
(a)
|
(b)
|
(c)
|
(c)
|
(c)
|
(c)
|
|
(d)
|
|
(e)
|
|
| |
|
|
Rate
|
|
Number of
|
|
|
|
|
|
| |
Identity of Issuer, Borrower, Lessor,
|
Description of
|
of
|
Maturity
|
Shares or
|
|
|
|
Current
|
|
| |
or Similar Party
|
Investment
|
Interest
|
Date
|
Units
|
|
Cost
|
|
Value
|
|
| |
|
|
|
|
|
|
|
|
|
|
| * |
Pfizer Inc. Common Stock
|
Common stock
|
|
|
93,657 |
|
$ |
2,268,322 |
|
$ |
2,868,714 |
|
| |
Zoetis Inc. Common Stock
|
Common stock
|
|
|
668 |
|
|
14,953 |
|
|
21,837 |
|
| |
Total common stocks
|
|
|
|
|
|
|
2,283,275 |
|
|
2,890,551 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| * |
NTGI - S&P 500 Equity Index Fund - Lending
|
Collective trust fund
|
|
|
3,518 |
|
|
12,704,363 |
|
|
20,436,997 |
|
| * |
NTGI - Russell 2000 Equity Index Fund -
|
|
|
|
|
|
|
|
|
|
|
|
| |
Lending
|
Collective trust fund
|
|
|
1,741 |
|
|
1,639,895 |
|
|
2,664,430 |
|
| * |
NTGI - Collective Government Short-Term
|
|
|
|
|
|
|
|
|
|
|
|
| |
Investment Fund
|
Collective trust fund
|
|
|
51,469 |
|
|
51,469 |
|
|
51,469 |
|
| |
Blackrock US Debt Index Fund K
|
Collective trust fund
|
|
|
81,480 |
|
|
2,303,426 |
|
|
2,459,478 |
|
| |
Blackrock US TIPS Index Fund K
|
Collective trust fund
|
|
|
3,508 |
|
|
47,060 |
|
|
44,513 |
|
| |
Robeco Large Cap Value Equity Fund
|
Collective trust fund
|
|
|
7,696 |
|
|
114,697 |
|
|
117,269 |
|
| |
T. Rowe Price Stable Value Common Trust Fund
|
Collective trust fund
|
|
|
24,188,258 |
|
|
24,230,519 |
|
|
24,573,928 |
|
| |
Vanguard Target Retirement Income Trust Plus
|
Collective trust fund
|
|
|
53,997 |
|
|
1,729,685 |
|
|
1,888,815 |
|
| |
Vanguard Target Retirement Trust 2015 Plus
|
Collective trust fund
|
|
|
10,257 |
|
|
361,470 |
|
|
393,567 |
|
| |
Vanguard Target Retirement Trust 2020 Plus
|
Collective trust fund
|
|
|
75,763 |
|
|
2,470,956 |
|
|
3,003,250 |
|
| |
Vanguard Target Retirement Trust 2025 Plus
|
Collective trust fund
|
|
|
18,737 |
|
|
682,552 |
|
|
762,395 |
|
| |
Vanguard Target Retirement Trust 2030 Plus
|
Collective trust fund
|
|
|
70,766 |
|
|
2,200,280 |
|
|
2,958,722 |
|
| |
Vanguard Target Retirement Trust 2035 Plus
|
Collective trust fund
|
|
|
3,988 |
|
|
152,159 |
|
|
171,038 |
|
| |
Vanguard Target Retirement Trust 2040 Plus
|
Collective trust fund
|
|
|
26,519 |
|
|
817,910 |
|
|
1,154,639 |
|
| |
Vanguard Target Retirement Trust 2045 Plus
|
Collective trust fund
|
|
|
550 |
|
|
18,949 |
|
|
23,934 |
|
| |
Vanguard Target Retirement Trust 2050 Plus
|
Collective trust fund
|
|
|
1,106 |
|
|
42,076 |
|
|
48,205 |
|
| |
Vanguard Target Retirement Trust 2055 Plus
|
Collective trust fund
|
|
|
457 |
|
|
17,089 |
|
|
19,891 |
|
| |
Total common/collective trust funds
|
|
|
|
|
|
|
49,542,294 |
|
|
60,772,540 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Dodge & Cox International Stock Fund
|
Mutual fund
|
|
|
44,333 |
|
|
1,526,691 |
|
|
1,908,082 |
|
| * |
Fidelity Large Cap Growth Fund
|
Mutual fund
|
|
|
7,115 |
|
|
702,485 |
|
|
851,697 |
|
| * |
Fidelity Low Price Stock Fund
|
Mutual fund
|
|
|
10,911 |
|
|
462,827 |
|
|
539,237 |
|
| * |
Fidelity Mid Cap Stock Fund
|
Mutual fund
|
|
|
14,066 |
|
|
437,992 |
|
|
555,604 |
|
| |
T. Rowe Price Small Cap Stock Fund
|
Mutual fund
|
|
|
4,410 |
|
|
164,509 |
|
|
196,495 |
|
| |
Oppenheimer Developing Markets Fund I
|
Mutual fund
|
|
|
18,513 |
|
|
609,125 |
|
|
695,515 |
|
| |
|
|
|
|
|
|
|
3,903,629 |
|
|
4,746,630 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Self-Directed Brokerage Account
|
Mutual fund
|
|
|
|
|
|
|
|
|
77,270 |
|
| |
Total mutual funds
|
|
|
|
|
|
|
|
|
|
4,823,900 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Total investments
|
|
|
|
|
|
|
|
|
|
68,486,991 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| * |
Notes receivable from participants
|
Interest Rates: 4.25% - 9.50%
|
|
|
|
|
|
|
|
|
1,226,593 |
|
| |
|
Maturity Dates: 2014 - 2025
|
|
|
|
|
|
|
|
|
|
|
| |
Total
|
|
|
|
|
|
|
|
|
$ |
69,713,584 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
* Party-in-interest as defined by ERISA |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
See accompanying report of independent registered public accounting firm. |
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE H, LINE 4j - SCHEDULE OF REPORTABLE TRANSACTIONS
|
|
|
Year Ended December 31, 2013
|
|
|
(thousands of dollars)
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
(h)
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
Current
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
value of
|
|
|
|
|
|
(a)
|
(b)
|
|
(c)
|
|
|
(d)
|
|
|
(g)
|
|
|
asset on
|
|
|
(i)
|
|
|
Identity of
|
Description
|
|
Purchase
|
|
|
Selling
|
|
|
Cost
|
|
|
transaction
|
|
|
Net gain/
|
|
|
party involved
|
of asset
|
|
price
|
|
|
price
|
|
|
of asset
|
|
|
date
|
|
|
(loss)
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NTGI - S&P 500 Equity Index Fund - Lending
|
Collective trust fund
|
|
$ |
2,222,505 |
|
|
$ |
- |
|
|
$ |
2,222,505 |
|
|
$ |
2,222,505 |
|
|
$ |
- |
|
|
NTGI - S&P 500 Equity Index Fund - Lending
|
Collective trust fund
|
|
|
- |
|
|
|
5,810,258 |
|
|
|
4,062,083 |
|
|
|
5,810,258 |
|
|
|
1,748,175 |
|
|
T. Rowe Price Stable Value Common Trust Fund
|
Collective trust fund
|
|
|
4,564,909 |
|
|
|
- |
|
|
|
4,564,909 |
|
|
|
4,564,909 |
|
|
|
- |
|
|
T. Rowe Price Stable Value Common Trust Fund
|
Collective trust fund
|
|
|
- |
|
|
|
5,580,513 |
|
|
|
5,580,513 |
|
|
|
5,580,513 |
|
|
|
- |
|
|
NTGI Collective Government Short Term Investment Fund*
|
Common / Collective Trust
(CCT) shares – 758 purchases
|
|
|
21,489,460 |
|
|
|
- |
|
|
|
21,489,460 |
|
|
|
21,489,460 |
|
|
|
- |
|
|
NTGI Collective Government Short-Term Investment Fund*
|
CCT shares – 1,514 sales
|
|
|
- |
|
|
|
21,453,483 |
|
|
|
21,453,483 |
|
|
|
21,453,483 |
|
|
|
- |
|
* Party-in-interest as defined by ERISA
See accompanying report of independent registered public accounting firm.
Pursuant to the requirements of the Securities Exchange Act of 1934, the members of the Savings Plan Committee have duly caused this annual report to be signed on its behalf by the undersigned, thereunto duly authorized.
.
| |
|
| |
|
WYETH UNION SAVINGS PLAN |
| |
|
|
| |
|
|
| |
By:
|
/s/ Brian McMahon |
| |
|
|
| |
|
|
| |
|
Brian McMahon |
| |
|
Member, Savings Plan Committee |
|
Date: June 26, 2014
|
|
|
16